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Abstract
Ibuprofen sodium salt (IP) was encapsulated in cyclodextrin nanosponges (CDNS) obtained by cross-linking of β-cyclodextrin with
ethylenediaminetetraacetic acid dianhydride (EDTAn) in two different preparations: CDNSEDTA 1:4 and 1:8, where the 1:n nota-
tion indicates the CD to EDTAn molar ratio. The entrapment of IP was achieved by swelling the two polymers with a 0.27 M solu-
tion of IP in D2O, leading to colourless, homogeneous hydrogels loaded with IP. The molecular environment and the transport
properties of IP in the hydrogels were studied by high resolution magic angle spinning (HRMAS) NMR spectroscopy. The mean
square displacement (MSD) of IP in the gels was obtained by a pulsed field gradient spin echo (PGSE) NMR pulse sequence at
different observation times td. The MSD is proportional to the observation time elevated to a scaling factor α. The α values define
the normal Gaussian random motion (α = 1), or the anomalous diffusion (α < 1, subdiffusion, α > 1 superdiffusion). The experi-
mental data here reported point out that IP undergoes subdiffusive regime in CDNSEDTA 1:4, while a slightly superdiffusive
behaviour is observed in CDNSEDTA 1:8. The transition between the two dynamic regimes is triggered by the polymer structure.
CDNSEDTA 1:4 is characterized by a nanoporous structure able to induce confinement effects on IP, thus causing subdiffusive
random motion. CDNSEDTA 1:8 is characterized not only by nanopores, but also by dangling EDTA groups ending with ionized
COO− groups. The negative potential provided by such groups to the polymer backbone is responsible for the acceleration effects
on the IP anion thus leading to the superdiffusive behaviour observed. These results point out that HRMAS NMR spectroscopy is a
powerful direct method for the assessment of the transport properties of a drug encapsulated in polymeric scaffolds. The diffusion
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properties of IP in CDNS can be modulated by suitable polymer synthesis; this finding opens the possibility to design suitable
systems for drug delivery with predictable and desired drug release properties.
Introduction
Cyclodextrin nanosponges (CDNS) are a novel, promising class
of nanoporous, three-dimensional polymers with interesting
properties of sorption of both organic and inorganic species
[1-3]. Indeed, several examples of applications can be found in
the recent literature, including biocatalysis [4], agriculture [5],
environmental control [6] and pharmaceutical applications such
as drug stabilization, enhancement of bioavailability and drug
delivery [7-11]. A typical synthetic protocol for their synthesis
consists of the condensation of OH groups of the glucose units
of cyclodextrin (CD) with a suitable, poly-functional cross-
linker agent, generally an activated derivative of a tetracar-
boxylic acid, such as ethylenediaminetetraacetic acid dianhy-
dride (EDTAn) [12], pyromellitic anhydride (PMA), or a phos-
gene synthetic equivalent as carbonyldiimidazole (CDI) or
diphenyl carbonate (DPC) [1-3]. For clarity, the corresponding
nanosponge will be indicated as CDNS followed by the
acronym of the cross-linker agent (e.g., CDNSEDTA for
cyclodextrin nanosponge polymerized with the EDTA deriva-
tive). The growth of the polycondensation products leads to a
statistic three-dimensional network characterized by different
types of cavities, namely the apolar cavity of the CD units and
the pores of the growing polymer. As previously stressed,
CDNS are, in the majority of cases, completely – or almost
completely – amorphous [13], thus preventing the possibility of
structural assessment via diffraction methods and making a
thorough structural characterization a still open investigation
field. The main structural features have been obtained, so far,
by a combined use of solid state 13C CP-MAS NMR, FTIR and
Raman spectroscopies [14-16].
CDNS are per se not soluble, due to the extended three-dimen-
sional covalent network. However, in many cases they showed
interesting swelling properties when contacted with water or
water solution only, affording hydrogels. The swelling ability of
CDNS depends on different factors, such as the chemical com-
positions of the nanosponge (e.g., CDNSPMA, CDNSEDTA
are swellable, CDNSDPC are not) and the cross-linker to CD
mole ratio n [17]. Recently, we demonstrated that the CDNS
hydrogels undergo phase transitions by changing the hydration
level h = m(H2O)/mCDNS by a complex interplay of physical
and chemical interactions [17,18]. The formation of hydrogel
from CDNS is of particular practical importance as it is an easy
and efficient way to load the gel with a given compound by
swelling the polymer in an aqueous solution of the molecule of
interest.
In the past few years the potential of CDNS as drug carriers has
been adequately underlined and recently reviewed in this
journal [19]. Indeed, CDNS can encapsulate either lipophilic or
hydrophilic active pharmaceutical ingredients, protect them
against undesired degradation, enhance water solubility when
necessary, facilitate their gradual release over extended times,
thus increasing the bioavailability at the target site [19]. In this
scenario of growing importance of CDNS in pharmaceutical
formulations as drug container and/or carrier, it is of paramount
importance a clear understanding, at molecular level, of the
state of the confined drug inside the polymeric network, espe-
cially in the gel state. To this end, the use of high resolution
magic angle spinning (HRMAS) NMR spectroscopy [20]
opened the possibility of using the whole repertoire of NMR
experiments to spot on the structural and dynamic properties of
the drug entrapped in the polymeric framework. HRMAS NMR
spectroscopy has become an extremely versatile technique that
provides high resolution NMR data on heterogeneous suspen-
sions [21], gels [22] and swellable solids [23]. The basic prin-
ciple is simple and can be summarized as follows: the dramatic
line broadening due to dipolar relaxation and magnetic suscepti-
bility inhomogeneity present in semi-solid or in heterogeneous
samples can be conveniently averaged to small or null values by
orienting the sample at the magic angle (β = 54.7°) with respect
to static B0 field and by spinning the sample at a rate in the
range of 2–10 kHz. These conditions are generally achieved by
using commercially available HRMAS probe-heads in a high
resolution NMR spectrometer. The sample is generally prepared
in the usual solid state rotors. Under these conditions, NMR
spectra with a typical resolution in the liquid state can be
obtained from samples not suitable for routine liquid state
NMR. Cutting-edge examples taken from the recent literature
include metabolomics [24,25], structure of organic ligands
bound to a solid support [26], and catalysis [27].
In addition to providing structural information, HRMAS NMR
has also been used to investigate transport phenomena in
heterogeneous systems endowed with liquid-like dynamics by
applying pulsed field gradient spin echo (PGSE) methodologies
under magic-angle spinning conditions [23]. This point is of
great interest in the field of controlled release of active pharma-
ceutical ingredients (API), as one of the possible release mecha-
nisms can be based on diffusion. The possibility of measuring
the transport properties of the API by a direct method (NMR)
and in the polymeric matrix effectively used for the formula-
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Figure 1: a) 1H high resolution NMR spectrum of IP dissolved in D2O, b) 1H HRMAS NMR spectrum of IP-CDNSEDTA (1:4) sample, c) 1H HRMAS
NMR spectrum of IP-CDNSEDTA (1:8) sample.
Table 1: Chemical shift (δ) of IP dissolved in D2O solution, and confined in CDNSEDTA (1:4) and CDNSEDTA (1:8).
sample chemical shifts (δ, ppm) and multiplicity of IP protons
3 (d) 4 (d) 2 (q) 5 (d) 6 (m) 1 (d) 7 (d)
D2O solution 7.31 7.19 3.66 2.47 1.87 1.45 0.89
CDNSEDTA 1:8 7.17 6.99 3.54 2.30 1.70 1.32 0.74
CDNSEDTA 1:4 7.11 6.88 n.d. 2.21 1.62 1.26 0.67
tion is therefore a physicochemical parameter directly related to
the potential use in therapy.
In this work we present a study based on HRMAS NMR spec-
troscopy on the transport properties of Ibuprofen sodium salt
(IP) confined in CDNSEDTA nanosponge hydrogels. Here, two
different formulation of the nanosponges are investigated, char-
acterized by a different CD/cross linker molar ratio: 1:4
(CDNSEDTA 1:4) and 1:8 (CDNSEDTA 1:8). The main
purpose of the work is to spot on the dynamic properties of this
popular analgesic, non-steroidal anti-inflammatory drug, in a
potentially useful cross-linked scaffold for advanced formula-
tions. The results point out that the diffusive regimes of IP in
the hydrogels strongly depend on the polymeric network
features and allow a modulation of the diffusivity as a function
of the polymer formulation.
Results and Discussion
HRMAS NMR spectra of IP confined in
CDNSEDTA
The 1H HRMAS NMR spectra of IP in CDNSEDTA (1:4) and
CDNSEDTA (1:8) polymer systems are shown in Figure 1
together with the 1H NMR spectrum of IP dissolved in D2O.
The molecular formula of IP (sodium salt, racemic mixture) and
the atom numbering are also shown.
Noticeably, the HRMAS spectra shows well resolved lines for
the IP molecule, comparable with the high resolution spectrum,
while CDNS gives broad overlapped resonances spanning the
range 3–4 ppm due to the slow mobility of the polymer
network. The chemical shifts (δ) of IP in D2O solution and in
CDNS gel are reported in Table 1. Chemical shift variations
(Δδ) of IP signals are observed on passing from the liquid D2O
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solution to the CDNS gel system, thus reflecting a different
molecular environment experienced by the drug molecule and
interactions with the polymeric backbone. Incidentally, no par-
ticular doubling of signals was observed due to the interaction
of the racemic IP with the chiral cavity of CDs in the
nanosponge gels. Conversely, significant doubling of selected
aromatic and methyl protons of IP was reported to take place in
the presence of monomeric β-CD in D2O solution, thus
confirming, in that case, the formation of an inclusion complex
and the chiral discrimination [28]. The absence of signal
doubling in the case described in the present work can be due to
either the absence of significant inclusion of IP in the CD
cavity, or to unresolved splitting due to broader signals. The
data of Table 1 show an upfield shift (lower δ value) in both gel
networks, and this shift is more pronounced in CDNSEDTA
(1:4). The chemical shift variations are more relevant for the
aromatic H(4) Δδ = 0.2–0.3 ppm upfield in gel, for the H(3)
Δδ = 0.14–0.2 and for the aliphatic H(6) Δδ = 0.17–0.25, thus
locating in the aromatic part of IP the major site of interaction
with the polymeric network.
HRMAS NMR diffusion measurements
Before any discussion on diffusivity of IP derived from NMR
data, it is worth summarizing here some key points on the diffu-
sion theory and the way diffusion can be studied by NMR. The
basic pulsed field gradient spin-echo (PGSE) experiments allow
to measure the molecular mean square displacement (MSD)
along the axis of the pulsed gradient (usually z-axis) with chem-
ical specificity. The PGSE sequence is based on a first defo-
cussing gradient of duration δ (little delta, few milliseconds.
This quantity is not to be confused with the chemical shift, indi-
cated by the same symbol in the text), followed by a free
precession delay during which diffusion takes place (big delta,
Δ), and a final refocusing gradient δ to achieve the echo. The
measurement is made over an overall observation time td,
(td = Δ−δ/3) and the molecular mean square displacement
(MSD) along the z reference axis  can be calculated by
fitting the gradient dependent signal intensities I(q,td) according
to Equation 1,
(1)
where q = γδg, γ is the magnetogiric ratio of the observed
nucleus, g is the applied field gradient, and δ is the gradient
pulse length. In the order, the first term is a constant, the second
and third are user controlled instrumental parameters. The MSD
of the diffusing molecule is proportional to the observation time
td:
(2)
The diffusion processes may be grouped in different classes,
depending on the value of the exponent α: i) isotropic unre-
stricted diffusion when α = 1, ii) anomalous subdiffusive regime
for 0 < α < 1, iii) anomalous superdiffusive regime for α > 1.
Recently, it was underlined the importance of anomalous diffu-
sion behaviours in complex systems such as polymeric
networks of supramolecular assemblies. Noticeable examples
reported in the recent literature deal with Pluronic F127 gel
[29], microemulsions [30], and layered media [31].
Equation 1 can be easily transformed in Equation 3:
(3)
After having carried out a collection of experiments at
increasing values of td, the normalized experimental signal
decays I(q, td)/I(0, td) can be plotted on a semilogarithmic scale
as function of q2 (Figure 2) for the set of diffusion times used,
td = 50–170 ms in our case. The plots are reported in Figure 2.
The liquid sample of IP dissolved in D2O (Figure 2a), as
expected for a pure isotropic liquid solution, shows a linear
dependence. The decay curves are obtained for the
IP-CDNSEDTA (1:4) and IP-CDNSEDTA (1:8) are shown in
panels b and c.
From the data summarized in Figure 2 for the three samples
studied, the MSD was calculated for several diffusion time td
values as function of q2 (Equation 2). It is important to note that
a log–log plot based on Equation 2 provides the experimental α
values as the slope of the linear regression. In other words, the
log–log plots provide immediate indication of the normal or
anomalous (sub- or superdiffusive) dynamic regimes of our sub-
strate confined in CDNS gels. The log–log plot is reported in
Figure 3 for each case. A scaling exponent α = 1 is obtained for
IP dissolved in D2O solution, thus indicating a Gaussian motion
in the liquid solution. The IP drug in gel system CDNSEDTA
(1:4) shows α = 0.64, indicating the presence of anomalous
diffusion with clear subdiffusive characteristics. IP in
CDNSEDTA (1:8) affords α = 1.06, thus indicating that also in
this case IP experiences anomalous diffusion towards a
superdiffusive regime. However, the small deviation of the
observed α from 1 is a caveat for the over-interpretation of the
data and suggests a thorough analysis of the MSD values.
The measured MSD are listed in Table 2 for five different diffu-
sion delays Δ. In the first column the MDS data are related to
Beilstein J. Org. Chem. 2014, 10, 2715–2723.
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Figure 2: Normalized NMR signal decay I(q,td) as function of q2 for a) IP in D2O solution, b) IP in CDNSEDTA (1:4), c) IP in CDNSEDTA (1:8).
Figure 3: log–log plot of MSD vs diffusion time td for: a) D2O solution, b) CDNSEDTA (1:4) and CDNSEDTA (1:8).
the behaviour of IP in water solution with a non-anomalous
diffusion regime. The ratio MSD (170 ms)/MSD (50 ms) can be
interpreted as the increment of the average surface explored by
IP in the time interval (120 ms). Such ratio for IP in water,
undergoing non-anomalous diffusion, is 3.41. The analogous
ratios for IP in CDNSEDTA (1:4) and CDNSEDTA (1:8) are
2.25 and 3.59, respectively. The former ratio is a clear indica-
tion of a deceleration effect with respect to the water solution,
in good agreement with the subdiffusive regime previously
mentioned on the basis of α = 0.64. The value obtained for
CDNSEDTA (1:8) is greater than the reference found for IP in
water and supports the hypothesis of anomalous diffusion with
a slightly dominant superdiffusive effect.
After examining the results of Figure 3 and Table 2, some
general and unprecedented conclusions can be drawn: i) the
same observed molecule (IP) displays significantly different
diffusive regimes in polymeric gels of cross-linked CDs. The
Beilstein J. Org. Chem. 2014, 10, 2715–2723.
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Figure 4: TEM images of: a) CDNSEDTA (1:4) and b) CDNSEDTA (1:8).
Table 2: MSD (m2) of IP dissolved in: solution, CDNSEDTA (1:4) and
CDNSEDTA (1:8) gel system at variable observation time td (s). Esti-
mated experimental errors: 0.5% for the solution, 1.6% for CDNS 1:4
and 2.3% for CDNS 1:8.






0.05 4.10E−11 9.93E−12 1.85E−11
0.08 6.38E−11 1.28E−11 2.69E−11
0.11 8.96E−11 1.59E−11 3.52E−11
0.14 1.15E−10 1.84E−11 5.51E−11
0.17 1.40E−10 2.25E−11 6.65E−11
transition from subdiffusive to (slightly) superdiffusive behav-
iour seems to be triggered, in the present study, by the polymer
preparation protocol only, having kept other factors – concen-
tration, temperature – constant. Additionally, as discussed in the
next paragraphs, the pH values measured in the two systems
span a limited range (6.5–6.9, vide ultra). ii) As a consequence,
a modulation of the diffusivity of a given substrate in the
polymer gels can be achieved by suitable polymer synthesis.
This fact opens the possibility of a rational design of drug
delivery/controlled release systems by controlling, inter alia, the
transport properties of the encapsulated drug. iii) HRMAS
NMR turned out to be a direct, efficient and quick method to
gain diffusivity data on API loaded in complex systems resem-
bling the formulations actually used for drug delivery, targeting
or controlled release.
Finally, the important issue of how subdiffusive and superdiffu-
sive regime can be related to the structure of the gel should be
addressed. In principle, the subdiffusive behaviour can be
related to the restricted diffusion of IP in the polymeric network
due to the presence of nanopores originated during the cross-
linking process. A visual description of the nanoporous struc-
ture of CDNSEDTA 1:4 is shown in Figure 4a.
The TEM image was recorded on samples stained with
Pb(NO3)2 to achieve sufficient contrast. The picture clearly
illustrates the porous morphology of the material and the struc-
tural heterogeneities in the pore size distribution. Confinement
effects are expected to drive the diffusion process from normal
to subdiffusive behaviour and interaction with the polymeric
constituents.
The interpretation of the superdiffusive regime observed for IP
in the CDNSEDTA 1:8 is less straightforward. In order to
account for the acceleration effect observed, we remind here
that the cross-linking process in CDNS showed a marked
dependence on the CD/cross-linker molar ratio. In a previous
work published by our group [32], the FTIR and Raman bands
in the 1680–1800 cm−1 wavenumber range were deconvoluted
in the two sub-bands ωCO1 (centered at 1730 cm−1) and ωCO2
(centered at 1750 cm−1) assigned to the stretching mode of C=O
in the ester and in the carboxylic acid functional groups, res-
pectively. The associated intensities ICO1 and ICO2 were related
to the populations of the two types of oscillators, namely COOR
and COOH. The quantitative analysis of the intensity ratio
ICO1/ICO2 showed that for molar excess less than a six-fold
excess of EDTA with respect to CD (1:6) the cross-linking
process was dominating. Larger excess of crosslinker (e.g.,
molar ratio greater that 1:6), caused branching of CD units
rather than increasing the cross-linking degree. The overall
result is an increasing number of dangling EDTA units with free
COOH groups at the end in the CDNS prepared with a large
excess of crosslinking agent. A simple scheme of these
processes is shown in Figure 5.
The ionization state of the COOH groups is thus expected to
play a key role in determining the possibility of a negative elec-
trostatic potential in part of the polymeric backbone, in turn a
possible cause of electrostatic acceleration leading to superdif-
fusive behaviour of the analyte IP. The ionization state of IP is
also playing a pivotal role in such mechanism, due to the fact
that a negative charge on IP may interact with the negative
potential of the polymeric matrix.
The pH measured in the two gels loaded with IP – CDNSEDTA
1:4 and CDNSEDTA 1:8 – were 6.9 and 6.5, respectively.
Beilstein J. Org. Chem. 2014, 10, 2715–2723.
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Figure 5: Effect of the increasing amount of crosslinker with respect to CD (expressed here as mol of crosslinker per mol of CD) on CDNS structure.
The cross-linking degree increased up to 1:6, then further excess of EDTA causes branching of CD units rather that further cross-linking.
Taking into account the literature pKa values [33] of EDTA for
the ionization of the four COOH groups ( pKa1 = 0.0,
pKa2 = 1.5, pKa3 = 2.0, pKa4 = 2.7), the contribution of the two
NH+ groups (pKa5 = 6.1, pKa6 = 10.4) and the pKa value of IP
in its acid form (4.91), it is reasonable assuming that the
majority of the COOH groups present in our systems are, in the
pH interval of our preparations, present in the COO− form and
that one NH+ group is significantly contributing. As a conse-
quence, an overall negative electric potential is expected in
some parts of the network. Electrostatic acceleration effects on
the random motion of the negatively charged IP molecules are
taking place, thus providing the driving force for the superdiffu-
sive component, as already found and reported in structurally
related systems [34]. However, as previously underlined, the
superdiffusive component is quite small. A simple electrostatic
model seems to be too approximated to justify the experimental
data. Rather, a complex superimposition of both superdiffusive
and subdiffusive components seems a better description of the
systems. The structure of the CDNSEDTA 1:8 is expected to
show a high degree of heterogeneity in the distribution of pores,
due to rearrangements caused by the steric hindrance. The TEM
image of Figure 4b shows the details of the pores heterogeneity
and the sponge-like morphology. The slightly superdiffusive
behaviour observed on IP in CDNSEDTA 1:8 can be rational-
ized as a complex balance of the confinement effects and the
electrostatic acceleration, with the latter dominating on the
former.
As a final remark, we mention that the pH variations occurring
during the preparative steps affording the drug-loaded hydro-
gels may, in principle, alter the structure of the polymeric
network. We are currently investigating this aspect by small
angle neutron scattering (SANS) on gels at variable and
controlled pH. The data collected at the Heinz Maier-Leibnitz
large scale facility (Munich, Germany, KWS-2 spectrometer)
are being processed and will be submitted elsewhere.
Conclusion
In conclusion, the present study demonstrated that HRMAS
NMR spectroscopy is a powerful method for the direct observa-
tion of molecular species confined in polymeric hydrogels. The
transport phenomena of IP in CDNSEDTA systems were
studied in terms of MSD at different observation times, high-
lighting the transition between a subdiffusive to a superdiffu-
sive regime modulated by the polymer structure in a small pH
interval (6.5–6.9). These findings, and the methodology
described for their assessment, can be exploited for the rational




CDNSEDTA were prepared by reacting β-CD, dissolved in an-
hydrous DMSO and in the presence of anhydrous Et3N, with
ethylenediaminetetraacetic acid dianhydride (EDTAn) at room
temperature for 3 hours under intense stirring, as previously
reported [17,31]. The obtained polymer was crushed in a mortar
and purified by washings with 0.2 M HClaq (3 times) and deion-
ized water (5 times) and finally dried under vacuum affording a
homogeneous powder. The cross-linker EDTAn was added at
molecular ratios 1:n (with n = 4, 8) giving two different prod-
ucts (Scheme 1).
Drug loading and NMR samples preparation
The encapsulation of IP in CDNSEDTA 1:4 and CDNSEDTA
1:8 for the preparation of the loaded gels for HRMAS NMR
analysis was done in three steps: (1) A 0.27 M stock solution of
Ibuprofen sodium salt was prepared by dissolving IP in deuter-
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Scheme 1: Schematic representation of the nanosponge synthesis. Acronyms: β-CD: β-cyclodextrin; EDTAn: anhydride of EDTA; CDNSEDTA:
cyclodextrin nanosponge obtained by using EDTAn as cross-linker.
ated water (99.8%). An analogous water solution was prepared
and its pH measured with a pH-meter giving the experimental
pH value of 8.2. (2) The step (1) solution (150 μL) was added to
a weighted amount (20 mg) of CDNSEDTA polymer in both
preparations. (3) 2 mg of Na2CO3 (10% w/w) was then added to
step (2) solution. After these steps, a perfectly homogeneous
and transparent gel without any visible phase separation or solid
particles was obtained in one hour. The preparations described
above were repeated on a larger scale and by using H2O in
order to obtain sufficient material for direct pH measurement
with a pH-meter. The observed pH for CDNSEDTA 1:4 and
CDNSEDTA 1:8 were 6.9 and 6.5, respectively. These values
can be considered a good approximation of pD of the HRMAS
NMR samples.
HRMAS NMR spectroscopy
All the spectra were recorded on a Bruker Avance spectrometer
operating at 500 MHz proton frequency, equipped with a dual
1H/13C HRMAS probe. Self diffusion coefficients were
measured by diffusion ordered correlation spectroscopy
(DOSY) experiments, based on the pulsed field gradient spin
echo (PGSE) pulse sequence. The duration of the magnetic field
pulse gradient (δ) in the z direction was optimized for each
sample in order to obtain complete dephasing of the signals
with the maximum gradient strength (G = 53.5 G cm−1). In each
DOSY experiment, a series of 32 spectra with 32 k points were
collected. For each experiment, 24 scans were acquired. Vari-
able Δ measurements of the investigated samples were carried
out by varying Δ in the range of 0.05–0.2 s, while the δ values
were in the range of 1.4–3 ms. The pulse gradients were incre-
mented from 2 to 95% of the maximum gradient strength in a
linear ramp. The temperature was set at 305 K (32 °C). Data
processing and fitting procedures were done by Dynamics
Center software (2.1.8 version) (Bruker). The experimental
error is between 2 and 3%.
TEM
Images were recorded on a Transmission Electron Microscope
Philips CM200 FEG at 200 kV electron accelerating potential.
CDNSEDTA 1:4 and CDNSEDTA 1:8 were swollen with a
solution of Pb(NO3)2 to obtain suitable gels containing the
contrast agent and sampled on a 300-mesh copper grid coated
with holey carbon film.
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